Mounjaro® (Tirzepatide) Injection 10 mg/0.5 mL – Prefilled Syringes (4-Pack, RX Only)

Description

By activating these hormone pathways, Mounjaro helps increase insulin release when blood sugar levels are elevated, reduce the release of glucagon (a hormone that raises blood sugar), and slow gastric emptying. These combined effects help stabilize blood sugar throughout the week and often contribute to reduced appetite and weight loss in patients with type 2 diabetes.

The 10 mg dose is typically prescribed for patients who have successfully titrated from lower doses and require additional glycemic control. Each carton contains four single-use, prefilled syringes, with one injection administered weekly. Mounjaro is injected just under the skin and is designed for convenient at-home use when prescribed by a licensed healthcare provider.

Mounjaro is not insulin and should not be used to treat type 1 diabetes. For best results, it should be used alongside a balanced diet, regular physical activity, and ongoing medical supervision.

How Mounjaro Is Used

Mounjaro is administered once per week, on the same day each week, by subcutaneous injection into the abdomen, thigh, or upper arm. Injection sites should be rotated to help reduce skin irritation. Before use, patients should inspect the syringe to ensure the solution is clear and that the medication has not expired.

After cleaning the injection site with an alcohol swab, the syringe is injected as directed. Each syringe is intended for single use only and must be disposed of in an approved sharps container after injection.

If a dose is missed, it may be taken as soon as remembered, provided the next scheduled dose is at least three days away. Patients should not take two doses within the same week unless instructed by their healthcare provider.

Unused Mounjaro syringes must be stored in the refrigerator and should never be frozen.

Important Medical Information

Mounjaro is available by prescription only and should be used exactly as directed by a healthcare professional. Blood sugar levels should be monitored regularly, and any side effects or concerns should be discussed with a licensed provider. Your healthcare provider will determine whether tirzepatide is appropriate for your diabetes management or medical weight loss plan.

---

Why Mounjaro Is Different

Unlike traditional GLP-1 medications, Mounjaro targets both GLP-1 and GIP receptors, two hormones that work together to regulate insulin secretion, glucose metabolism, and appetite. This dual-action approach helps improve insulin sensitivity and blood sugar control more effectively, which is why tirzepatide has become a leading option in modern diabetes treatment and physician-supervised weight management programs.